Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1613-7671
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding ; day:20 ; month:8 ; year:2018 ; pages:1-13
Wiener klinische Wochenschrift ; (20.8.2018), 1-13
- Urheber
- Beteiligte Personen und Organisationen
-
Niessner, Alexander
Domanovits, Hans
Frossard, Martin
Sengölge, Gürkan
Steinlechner, Barbara
Sycha, Thomas
Wolzt, Michael
Pabinger-Fasching, Ingrid
SpringerLink (Online service)
- DOI
-
10.1007/s00508-018-1381-5
- URN
-
urn:nbn:de:101:1-2018101521202121721173
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gremmel, Thomas
- Niessner, Alexander
- Domanovits, Hans
- Frossard, Martin
- Sengölge, Gürkan
- Steinlechner, Barbara
- Sycha, Thomas
- Wolzt, Michael
- Pabinger-Fasching, Ingrid
- SpringerLink (Online service)
Ähnliche Objekte (12)
Non-vitamin K oral anticoagulants associated bleeding and its antidotes
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis
Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Non-vitamin K oral anticoagulants associated bleeding and its antidotes
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis
Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Non-vitamin K oral anticoagulants associated bleeding and its antidotes
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis
Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry